Systemic haemorrhage in rats induced by a haemorrhagic fraction from Bothrops jararaca venom.
The main haemorrhagic fraction of Bothrops jararaca venom, showing in vitro fibrinogenolytic activity and an inhibitory effect on platelets aggregation induced by collagan, was studied in rats. Development of coagulopathy and/or haemorrhage was studied 2 hr after s.c. injection of batroxobin, B. jararaca whole venom and its haemorrhagic fraction. Incoagulable blood, together with low fibrinogen levels, were found only in rats injected with batroxobin and whole venom; thrombocytopenia alone was detected in rats given s.c. injections of haemorrhagin. Intravenous injection of low doses of haemorrhagin (less than 15 micrograms) resulted in significant thrombocytopenia, without any alterations in the blood coagulation mechanism. Severe damage to the vascular endothelium and skeletal muscle following s.c. injection of haemorrhagin together with signs of systemic haemorrhage in the kidneys, lungs and liver occurred. Levels of factor VIII and von Willebrand factor antigen were within the normal range in all animals. Serum levels of both whole venom and haemorrhagin were significantly correlated. This study confirms that B. jararaca haemorrhagin plays a vital role in systemic bleeding.
Kamiguti
A S
AS
Department of Haematology, Royal Liverpool Hospital, U.K.
Theakston
R D
RD
Desmond
H
H
Hutton
R A
RA
D000818:Animals; D012103:Batroxobin / Q000008:administration & dosage / Q000633:toxicity*; D001777:Blood Coagulation; D005591:Chemical Fractionation; D002851:Chromatography, High Pressure Liquid; D003435:Crotalid Venoms / Q000633:toxicity*; D004730:Endothelium, Vascular / Q000473:pathology; D005340:Fibrinogen / Q000032:analysis; D006470:Hemorrhage / Q000209:etiology* / Q000473:pathology; D008297:Male; D010974:Platelet Aggregation; D051381:Rats; D011919:Rats, Inbred Strains
D003435:Crotalid Venoms; C032814:hemorrhagin components (Crotalid); C030961:botrocetin; D005340:Fibrinogen; D012103:Batroxobin